Refactor Capital — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Able Health provides software for physician organizations to administer value-based care programs, including quality measure calculation and health plan coordination to reduce administrative overhead.
HealthtechSan Francisco, US
Rachel Katz(CEO)inSteve Daniels(President)in
Co-investorsLifeforce CapitalMission and MarketSoma CapitalY CombinatorFifty YearsGreat Oaks Venture Capital
Bulk MRO operates a B2B supply chain and finance platform serving enterprise, government, and SME customers with industrial products, metals, agro-commodities, chemicals, and logistics services.
B2B MarketplacesEnterprise SoftwareFintechLogistics & Supply ChainSaaSNew York City, US
Devang Shah(Founder)inGaurang Shah(Director)inCharles Lorenceau(Director)Sergio Pereira(CTO)
Co-investorsAAF Management Ltd.Afore CapitalFJ LabsRebright PartnersSwitch VenturesY Combinator+10 more
Orchid offers whole genome sequencing-based genetic screening of embryos during IVF as well as preconception testing for couples, analyzing DNA to identify predispositions to monogenic diseases, chromosomal abnormalities, and polygenic risks.
BiotechDigital HealthFemTechSan Francisco, US
Alexandra Meyer(President and Chief Executive Officer of Issuer)
BoardEmily Anhalt(Director of Issuer)
Co-investorsBalaji SrinivasanBlockchain CoinvestorsCarnrite VenturesEnsemble LabsHartmann CapitalPebblebed+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













